Progesterones and Breast Cancer Endogenous and Exogenous Synthetic or Natural Bio-identical Progestins, Progestogens or Progestagens “Act like progesterone”

Slides:



Advertisements
Similar presentations
((Hormone replacement therapy))
Advertisements

HORMONE REPLACEMENT, AN OVERVIEW DR SARAH WHITFIELD.
Dysmenorrhea, Menopause, Fibrocystic Breast Disease Ricci, pp ; 101, 150;
Menopause and HRT. AIMS Menopause : How to diagnosis Symptoms Treatments Premature menopause HRT : indications/contraindications.
What’s New in Adolescent Contraception? Rachel S-D Fortune, MD, FAAP Medical Director, Newport Academy.
 Ultrasound pelvis  Full blood count  Pap smear  Coagulation profile  Liver function tests  Serum Iron  Serum ferritin  Endometrial biopsy 
Hormone Replacement Therapy Dr Belinda Magnus. Menopause - Background  Vasomotor symptoms affect around 80% women during the menopause – severe in 20%
Feed back control HBS3A. Simple negative feedback systems.
Contraceptive Options for Women and Couples with HIV Implants, POPs and Emergency Contraception.
The Pill The Autism Epidemic & The Pill Dr Ellen CG Grant Pub Med grant ec.
What women can do to stay healthy Valerie Beral University of Oxford THE MILLION WOMEN STUDY.
Family planning Clinic of Reproduction and Gynecology PAM.
HRT In a nutshell for all the blokes out there. diagnosis  Clinical hx  FSH limited value as levels fluctuate  May be of value in symtomatic women.
Abnormal uterine bleeding
DYSFUNCTIONAL UTERINE BLEEDING
Barbora kubešová. Contraception Techniques to prevent pregnancy - family planning - population control Pearl index … number of pregnancies x.
Protein Mutations in Disease Lecture 11, Medical Biochemistry.
Hormonal and Surgical Contraception
Infertility In Women Lesson 2.
Menstrual cycle Lecture 2.
Female Sex Hormones (Estrogens and Progestins)
Sexual Reproduction in the Human (Extended Study).
Certain facts & myths about contraception Who needs contraception All the women who have not achieved menopause and are sexually active need contraception.
DR MANAL IDRIS menorrhagia. Introduction Menorrhagia is one of the commenest gynaecological complaints seen in practice and accounts for approximately.
Failure rates. Contraceptive use - USA Female sterilization27% OC 26% Male condom20% Male sterilization10% Withdrawal3% Injectable (MPA)3% Diaphragm2%
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 62 Birth Control.
ESTROGENS AND ANDROGENS
Ovarian Cancer Research in Allied Health Erin Brewer.
Contraceptive Methods Ana H. Corona, MSN, FNP-C March 2009 Revised.
Estrogen & Progesterone
Reproductive Hormonal Pharmacology Douglas Danforth, Ph.D. The Ohio State University.
Unscheduled bleeding in young women Dr Kathryn Hill GPST2 in O+G.
Hormonal Contraception ผศ. พญ. มาลียา มโนรถ. Hormonal Contraception Oral contraceptives (OCs) Combination of estrogen & progestogen Progestogen only Postcoital.
Pharmacotherapy of Sexual Offenders Paraphilias Paraphilias –Includes exhibitionism, fetishism, frotteurism, pedophilias, sexual masochism or sadism, travestic.
Hormones Topic B6. Production and function (B.6.1) primarily chemical messengers produced in endocrine glands – –organs that secrete directly into bloodstream.
Sexual Reproduction in the Human
ENDOMETRIOSIS. Definition Is a condition in which tissues similar to normal endometrium in structure and function are found in sites other than the lining.
What does it mean to age? Deterioration over time! This can include; weakness, susceptibility to disease, loss of mobility and agility. The reduced ability.
Obs & Gynae Pearl Index: measures the number of pregnancies that occur for each contraceptive method if used by 100 women for one year.  Perfect.
Hormonal Contraceptives. 2 A. Hormonal Contraceptives 1.Combined Oral Contraceptive Pills (COCPs) – Contain both estrogen and progesterone 2.Progestin.
Estrogens and Androgens
Dr. Areej M. Al-Taweel Pharmacognosy Department Pharmacognosy Department.
Hormonal Birth Control and the Ovarian Cycle Cara Beth Rogers Tanja Mehlo.
Describe the symptoms, causes, and treatments of: Female infertility Ovarian Cysts Breast Cancer Human Papillomavirus.
Oral contraceptives.
NUR 210: Women’s Health Agents Pharmacology: Wanda Lovitz, APRN.
Effects of using Progestins and Estrogens 55 years OCs + HT ↑ Cancers, Vascular, Mental and other diseases Why?
Progestogen-only contraception
Family Planning - Dr Sienna Tran
Combined Oral Contraceptives
MENOPAUSE.
Endometrial hyperplasia
Contraception Update.
Endocrine Pharmacology
Sexual Reproduction in the Human
Contraception in the over 40’s
Contraception 1.
Ch. 32 Warm-Up What type of behavior in animals might be triggered by cold temperatures? What type of behaviors might be triggered in hot temperatures?
Dr Fulufhelo Tshivhula Specialist Gynaecologist Polokwane
Principles of Pharmacology The Pathophysiologic Basis of Drug Therapy
c The biology of controlling fertility
Ch. 32 Warm-Up What type of behavior in animals might be triggered by cold temperatures? What type of behaviors might be triggered in hot temperatures?
Menstrual cycle Lecture 2.
Chapter 62 Birth Control 1.
Hormone Replacement Therapy (HRT)
EMERGENCY CONTRACEPTION SHumi Negesse, MD Assistant Professor, Adama hospital medical college Department of OBSTETRICS AND GYNECOLOGY.
Sexual Reproduction in the Human
Ch. 32 Warm-Up What type of behavior in animals might be triggered by cold temperatures? What type of behaviors might be triggered in hot temperatures?
Presentation transcript:

Progesterones and Breast Cancer Endogenous and Exogenous Synthetic or Natural Bio-identical Progestins, Progestogens or Progestagens “Act like progesterone” Dr Ellen C G Grant Dr Ellen C G Grant MBChB, DObst RCOG

Contraceptive and Menopausal Progestogens and Oestrogens W H O International Agency for Research in Cancer (IARC monograph, 2005)W H O International Agency for Research in Cancer (IARC monograph, 2005) “Group 1 Carcinogen”“Group 1 Carcinogen” Highest level (dioxin, mycotoxins) Direct GenotoxinsDirect Genotoxins

Collaborative (51), MWS, WHI xs Breast Ca5 yr 10 yrStudyxs Breast Ca 5 yr 10 yr Study Oestrogen HRTCollabOestrogen HRT 2 6 Collab MWS MWS P plus O HRTMWSP plus O HRT 6 19 MWS WHI 6 18 WHI Beral Lancet 2003Beral Lancet 2003 HRT Studies (1.09 – 19) 2 – 8

Contraceptive Breast Cancer Risks OESTROGEN + PROGESTOGENOESTROGEN + PROGESTOGEN Combined OCs ( ) By age 50 before FFTP1.52By age 50 - Ever use ≥ 4yrs before FFTP 1.52 Kahlenborn,2006Kahlenborn,2006 Ethinyl oestradiolCombined OCs + Ethinyl oestradiol 35 mcg 2 >35 mcg 4 PROGESTOGENPROGESTOGEN only (UK study, P mostly lactation 1 – 12 months)

Breast cancer ↑↑ with P use

Progesterone carcinogenesis Progesterone 3-4 x more breast cancersOestrogen?Why does Progesterone cause – 3-4 x more breast cancers than Oestrogen? 4 x more genes up or down regulated4 x more genes up or down regulated All tissues Carcin ogenic MetabolitesAll tissues Carcin ogenic Metabolites + or - Progesterone Receptors+ or - Progesterone Receptors Angiogenesis ↑ ↑ Immune diseases ↑ ↑ (x9)Angiogenesis ↑ ↑ Immune diseases ↑ ↑ (x9)

Actions of Progesterone ↑ oestrogen priming↑ oestrogen priming Subnuclear vacuolesSubnuclear vacuoles ESP Alkaline phosphatase ↓↓ESP Alkaline phosphatase ↓↓ Acid phosphatase, SODase, COMT ↑↑Acid phosphatase, SODase, COMT ↑↑ LSPMonoamine oxidase ↑↑LSP Monoamine oxidase ↑↑ Immediate Angiogenesis ↑↑Immediate Angiogenesis ↑↑

Normal endometrial cycle 2 days subnuclear vacuoles mid cycle2 days subnuclear vacuoles mid cycle

P treated endometrium

Normal Late Secretory

Progestogenic ++ arterioles ++

Dilated sinusoid - thrombosis

Thrombosedcerebral vessels – 5 yrs OC Thrombosed cerebral vessels – 5 yrs OC

Norgestrel Dose Effects

↑↑ Aggression ↑Vascular

Types of Progestogens AndrogenicPregnanes Androgenic Pregnanes EstranesGonanes Estranes Gonanes MPA - depotOCs MPA - depot MPA inHRT 13 5 MPA in USA MPAMAMPA and MA (banned UK 1970s) Breast cancer small or largedosesBreast cancer small or large doses

Progestogen Potency ANDROGENICPROGESTOGENIC ANDROGENIC PROGESTOGENIC Estrane Gonane PregnaneEstrane Gonane Pregnane NorethisteroneMPANorethisterone 1 dl-Norgestrel 2.6 MPA 0.3 N AcetateN Acetate 1.2 MA 0.4 Oral ProgesteroneMicronised x 2 potency - Oral Progesterone Levonorgestrel Levonorgestrel 5.3 Norgestimate Norgestimate 1.3 Desogestrel Desogestrel 9 Gestodene Gestodene 12.6

Actions of Progesterone Blocks FSH and LH - prevents ovulationBlocks FSH and LH - prevents ovulation Switches immune balance T1 → T2Switches immune balance T1 → T2 Antibody production ↓↓Antibody production ↓↓ Symptoms – increased - decreasedSymptoms – increased - decreased Immune diseases - PMS, SLE

Genetics and Epigenetics Epigenetics – changes in gene functionEpigenetics – changes in gene function 12,686 genes implantation windowKoa ,686 genes implantation window I in 25 genes activatedI in 25 genes activated Progesterone 4 x genes cf OestrogenProgesterone 4 x genes cf Oestrogen

Progesterone –activated genes 377 up regulated377 up regulated 156 down regulated156 down regulated Striking Regulation of Secretory ProteinsStriking Regulation of Secretory Proteins Water and Ion ChannelsWater and Ion Channels Signalling MoleculesSignalling Molecules Immune ModulatorsImmune Modulators Endometrial DevelopmentEndometrial Development Embryonic Interactions.Embryonic Interactions.

P upregulated genes cholesterol trafficking and transportcholesterol trafficking and transport apolipoprotein E 100-foldapolipoprotein E 100-fold prostaglandin (PG) biosynthesis (PLA2) and action (PGE2 receptor) proteoglycan synthesis (glucuronyltransferase), secretory proteins (glycodelin, mammaglobin, Dickkopf-1 - a Wnt inhibitor), IGF binding protein and TGF-beta superfamilies, signal transduction, extracellular matrix components (osteopontin, laminin) neurotransmitter synthesis -MAO, receptorsneurotransmitter synthesis -MAO, receptors

P down regulated genes Intestinal Trefoil Factor (ITF) - 50-foldIntestinal Trefoil Factor (ITF) - 50-fold matrilysin, members of the G protein-coupled receptor signaling pathway, frizzled-related protein (FrpHE, a Wnt antagonist) Transcription Factors, TGF-beta signaling pathway membersTranscription Factors, TGF-beta signaling pathway members Immune Modulators(major histocompatibility complex class II subunits) and other cellular functions Immune Modulators (major histocompatibility complex class II subunits) and other cellular functions

P up regulated genes Numerous Immune ModulatorsNumerous Immune Modulators Detoxification genes MetallothioneinsDetoxification genes Metallothioneins Genes involved in water and ion transport - K(+) ion channelGenes involved in water and ion transport - K(+) ion channel Genes corresponding to IGFBP-1, glycodelin, CPE1-R, Dkk-1, mammaglobin, and ApoDGenes corresponding to IGFBP-1, glycodelin, CPE1-R, Dkk-1, mammaglobin, and ApoD.

↑↑Cu/Zn ratios in sweat (serum and hair) in treated women - parts per billion at Biolab ↑↑ Cu/Zn ratios in sweat (serum and hair) in treated women - parts per billion at Biolab

RCGP OC Study Vascular DVTHROMBOSIS /PE DVTHROMBOSIS /PE 5.66 Heart disease 5.2 Deaths Cerebrovascular 4.1 Deaths Vascular Vascular 4.2 non smoker smoker AMI +Toxaemia history 41.0 Cerebrovascular +10 years Cerebrovascular +10 years 2.7

RCGP OC Study - Cancers Breast cancer age Breast cancer age Breast + 10 yrs Breast 8-9 yrs later 15.8 Breast cancer deaths1.5Breast cancer deaths yrs later 1.5 Lung cancer 1.6Lung cancer yrs 1.6 Liver cancer 5 5.0Liver cancer 5 5.0

RCGP OC Study Cervical cancerDeaths > 10yrs 5.3Cervical cancer Deaths > 10yrs 5.3 Pruritis, vaginitis, 2 Trichomonas, leukorrhoea, cervicitis 1.6Trichomonas, leukorrhoea, cervicitis 1.6 Ex OC Irregular bleeding 1.55Ex OC Irregular bleeding 1.55 Fibroids 2.5Fibroids 2.5 Post Pill amenorrhoea - infertility 3.2Post Pill amenorrhoea - infertility 3.2 Abortions 13.3% → 30.61%Abortions 13.3% → 30.61%

RCGP OC STUDY NOT “ALL CLEAR” NOT “ALL CLEAR” Over 60 conditions increased Over 60 conditions increased immune diseases, infections and allergies immune diseases, infections and allergies SERIOUS IMMUNE DYSFUNCTION DYSFUNCTION

Walnut Creek OC Study Cervical cancer x12Cervical cancer x12 Ovarian retention cystsOvarian retention cysts Severe acute iron deficiency anaemiaSevere acute iron deficiency anaemia Fibroids (vascular)Fibroids (vascular) Adenomyosis ( endometriosis )Adenomyosis ( endometriosis ) Hysterectomies < age % x2.5Hysterectomies < age % x2.5 All Significantly Increased → HRT “use” ++All Significantly Increased → HRT “use” ++

Endocrine-disrupting chemicals Over 70 years of animal researchOver 70 years of animal research Hormones organise the brainHormones organise the brain Peri-natally - critical timingPeri-natally - critical timing Modify sexuality, perception and learning Endogenous - twins - risk taking – aggressionEndogenous - twins - risk taking – aggression Aromatase inhibitors, pesticides, fungicidesAromatase inhibitors, pesticides, fungicides Crews and McLachlan 2006Crews and McLachlan 2006

Fertility and pregnancy hormonal “treatments” Genital organ malformations infertility treatmentGenital organ malformations infertility treatment HR 2.32HR 2.32 Zhu JL, Danish national birth cohort. BMJ, 2006 Progesterone /progestogensProgesterone /progestogens 4 weeks before to14 weeks after conception4 weeks before to14 weeks after conception HYPOSPADIAS OR 3.7HYPOSPADIAS OR 3.7 Carmichael 2005

Effects of P on development Most pregnancy Progesterone use nowMost pregnancy Progesterone use now ↑ Cancers in children, DES breast, vaginal↑ Cancers in children, DES breast, vaginal Testicular Leukaemia NeuroblastomasTesticular Leukaemia Neuroblastomas Brain Development ↓ Stress coping ↑ Mental illness ↑ Autism x4Brain Development ↓ Stress coping ↑ Mental illness ↑ Autism x4 Sexual Orientation - Organ AbnormalitiesSexual Orientation - Organ Abnormalities Immune Dysfunction ↑ AllergiesImmune Dysfunction ↑ Allergies

Progesterone carcinogenesis A Preventable Epidemic ?A Preventable Epidemic ? WHI, MWS and WISDOM HRT trials terminated earlyWHI, MWS and WISDOM HRT trials terminated early but very young OC usebut very young OC use very high doses ECsoff prescription very high doses ECs depot MPA still vigorously promoteddepot MPA still vigorously promoted

Ellen Grant on line J Nutr Environ Med June 1998J Nutr Environ Med June 1998 Grant, Ewww.bmj.com Search - Grant, E Articles and Rapid Responses grant ecNCBI - grant ecwww.pubmed.gov